Latest Diasorin News & Updates

See the latest news and media coverage for Diasorin. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Diasorin

Manufacturer of immunodiagnostic and molecular diagnostic systems

diasorin.com
Headquarters
Saluggia, Italy
Company type
Public company
Number of employees
2,500–5,000

Last updated

Latest news about Diasorin

In short: Diasorin approved its 2026-2030 industrial plan and secured multiple FDA clearances, though first-quarter 2026 revenues declined by 8 percent.

Company announcements

Diasorin

Diasorin reports Q1 2026 financial results

Revenues reach €287 million (-3% at CER), adjusted EBITDA €90 million (31% margin). Confirms 2026 guidance of 5-6% revenue growth. Launches LIAISON NES in US.

Unlock all announcements with a

Media coverage

Milano Finanza

MARKET DRIVER: Diasorin, DB goes to sell

Real-time financial news from MF Market Driver. Follow the market trends, stock exchange listings and the main national economy news and...

Investieren 24

Ftse Mib: The winners and losers of the week under geopolitical influence | Investieren 24

While MPS and other banks benefited from the positive developments, Diasorin recorded a significant price decline of 3.9%.

Unlock all articles with a

Never miss news about Diasorin

Track Diasorin and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Diasorin competitors & trending companies

Browse news for competitors to Diasorin and other trending companies.